Sensei Biotherapeutics, Inc.
SNSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $246,147 | $386,856 | $914,958 | $3,214,440 |
| - Cash | $9,994 | $13,011 | $17,795 | $7,159 |
| + Debt | $3,845 | $6,208 | $8,033 | $2,354 |
| Enterprise Value | $239,998 | $380,053 | $905,196 | $3,209,635 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$551 | -$571 | -$1,808 | -$685 |
| % Margin | – | – | – | – |
| EBITDA | -$29,516 | -$33,386 | -$46,561 | -$35,439 |
| % Margin | – | – | – | – |
| Net Income | -$30,157 | -$34,101 | -$48,588 | -$36,794 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.2 | -1.22 | -1.58 | -1.33 |
| % Growth | 1.6% | 22.8% | -18.8% | – |
| Operating Cash Flow | -$24,670 | -$32,023 | -$39,026 | -$30,259 |
| Capital Expenditures | -$146 | -$180 | -$321 | -$2,026 |
| Free Cash Flow | -$24,816 | -$32,203 | -$39,347 | -$32,285 |